Asthma and chronic obstructive pulmonary disease (COPD) are complex and overlapping
diseases that include inflammatory phenotypes. Novel anti-eosinophilic/anti-neutrophilic …

Background Electronic noses (eNoses) are emerging point-of-care tools that may help in
the subphenotyping of chronic respiratory diseases such as asthma. Objective We aimed to …

Background Patients with COPD are at high risk of lung cancer developing, but no validated
predictive biomarkers have been reported to identify these patients. Molecular profiling of …

… te Nijenhuis has nothing to disclose; Rianne de Vries reports personal fees and other from
Breathomix BV, outside the submitted work; Yennece WF Dagelet has nothing to disclose; …

… 1 , Yennece WF Dagelet …

Introduction: Electronic noses (eNoses) detect mixtures of volatile organic compounds (VOCs)
in exhaled breath via a set of cross reactive sensors. eNose breathprints have the …

Rationale: Analysis of exhaled volatile organic compounds (VOCs) by sensor-driven electronic
nose (eNose) technology is a widely suggested measure for non-invasive monitoring of …

Introduction: COPD is a heterogeneous disease with differences in response to treatment.
Efforts are ongoing to find new biomarkers that are able to stratify patients at the point-of-care. …

Rationale: Clinical/inflammatory phenotypes of chronic airway disease have been obtained
by eNose, irrespective of the diagnostic label [De Vries ERJ 2018]. This requires prospective …

Introduction: The coronavirus disease 2019 (COVID-19) pandemic has led to the death of
almost 7 million people, however, with a cumulative incidence of 0.76 billion, most people …